TD Cowen on Royalty Pharma (RPRX): BIIB Ph2 results 'de-risks upside potential for royalty' Mar 31, 2026 08:14AM
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing Mar 2, 2026 06:10AM
Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma Mar 2, 2026 06:01AM
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing Mar 2, 2026 06:01AM
Royalty Pharma (RPRX) PT Raised to $50 at TD Cowen Feb 27, 2026 01:43PM


Feb 26, 2026 04:15PM Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
Dec 11, 2025 10:12AM Royalty Pharma (RPRX) PT Raised at TD Cowen; 'Best Ideas 2026: Unique Business'
Sep 12, 2025 09:16AM TD Cowen Reiterates Buy Rating on Royalty Pharma (RPRX)
Feb 27, 2025 04:15PM Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference
Jan 7, 2025 11:00AM TD Cowen on Pharma: '10 Events in 2025 That Could Change Practice, Alter Companies, Move Stocks'
Nov 7, 2024 07:11AM Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Geron’s (GERN) RYTELO for $125M
Nov 7, 2024 07:10AM Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
Oct 7, 2024 09:28AM TD Cowen Reiterates Buy Rating on Royalty Pharma (RPRX)
May 17, 2024 02:07PM TD Cowen Reiterates Buy Rating on Royalty Pharma (RPRX)
Feb 28, 2024 04:15PM Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
Jan 9, 2023 09:15AM Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial Readiness
Jan 9, 2023 09:15AM Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial Readiness
Jan 9, 2023 09:06AM Ionis Pharmaceuticals (IONS), Royalty Pharma (RPRX) enter into royalty agreement for up to $1.1 billion
Jan 9, 2023 09:05AM Ionis and Royalty Pharma enter into royalty agreement for up to $1.1 billion to further advance Ionis' genetic medicines and commercial readiness
Jun 30, 2022 07:16AM Blueprint Medicines (BPMC) Enters $1.25B Strategic Financing Collaborations with Sixth Street and Royalty Pharma (RPRX)
Jun 30, 2022 07:15AM Blueprint Medicines Announces Transformative $1.25 Billion Strategic Financing Collaborations with Sixth Street and Royalty Pharma
Mar 3, 2022 08:30AM Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference
Mar 3, 2022 08:30AM Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference
Nov 22, 2021 07:12AM Royalty Pharma plc (RPRX) Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst (BCRX) for $350M
Nov 22, 2021 07:10AM Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals
Nov 22, 2021 07:10AM Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals
Nov 22, 2021 07:06AM BioCryst Pharma (BCRX) Adds $350 Million in New Financing with Royalty Pharma (RPRX) and OMERS Capital Markets
Dec 7, 2020 08:48AM BioCryst Pharma (BCRX) Announces $325 Million of Funding from Royalty Pharma (RPRX) and Athyrium Capital Management
Dec 7, 2020 08:45AM Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
Dec 7, 2020 08:45AM Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
Dec 7, 2020 08:40AM BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
Oct 20, 2020 04:32PM Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
Oct 20, 2020 04:32PM Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
Oct 16, 2020 05:47AM Royalty Pharma plc (RPRX) Prices 17.34M Class A Share Secondary Offering at $42/Sh by Selling Shareholders
Oct 15, 2020 11:45PM Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
Oct 15, 2020 11:45PM Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
Oct 13, 2020 04:11PM Royalty Pharma (RPRX) Announces 17.3M Secondary Offering of Class A Ordinary Shares by Selling Shareholders
Oct 13, 2020 04:10PM Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders
Oct 13, 2020 04:10PM Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders
Jul 13, 2020 05:49AM Cowen Starts Royalty Pharma (RPRX) at Outperform
Jun 18, 2020 04:15PM Royalty Pharma Announces Closing of Initial Public Offering
Jun 18, 2020 04:15PM Royalty Pharma Announces Closing of Initial Public Offering
Jun 16, 2020 12:07PM Royalty Pharma plc (RPRX) IPO Opens 57% Higher
Sep 8, 2016 09:29AM Pre-Open Stock Movers 09/08: (RPRX) (RAD) (JUNO) Higher; (GEVO) (NLST) (TSCO) (PIR) Lower (more...)
Oct 17, 2014 09:34AM Pre-Open Stock Movers 10/17: (ESI) (SRPT) (QLGC) Higher; (RPRX) (URBN) (MYGN) Lower
Sep 26, 2014 09:27AM Pre-Open Stock Movers 9/26: (JNS) (NKE) (MU) Higher; (ACRX) (FINL) (BBRY) Lower (more...)